Replies to post #458663 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Nice thought and good work on this. It is beginning to look and feel like AVXL are beginning to move the ball down the field. Lots of big and important things happening...NICE TO SEE.

Thx georgejjl

The first cohort of Part A of the phase 2 Anavex 3-71 schizophrenia has completed enrollment. I believe that the second cohort of Part A of the phase 2 Anavex 3-71 schizophrenia will be completed by or before summer 2024 and that the entire phase 2 Anavex 3-71 schizophrenia trial will be completed before the end of summer 2024.

https://classic.clinicaltrials.gov/ct2/show/NCT06245213

[ignatiusrielly35]

I’m having difficulty interpreting the Schizo trial description in the PRs. It seems vague to me. Part A will be a 28-day dose determination leg? Part B will then be a 28-day POC leg based on the dosage determined from Part A?

Will both Part A and Part B have cohorts that receive either 10 days or 28 days of dosing?